Treatment News : Substance Use Doesn’t Increase Risk of Neurocognitive Problems in HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 12, 2011

Substance Use Doesn’t Increase Risk of Neurocognitive Problems in HIV

Neurocognitive problems—notably HIV-associated neurocognitive disorder (HAND)—are no more likely to occur in illicit substance users compared with non-substance users, according to a report published ahead of print on the Journal of Acquired Immune Deficiency Syndromes website.

These findings are surprising, writes Desiree Byrd, PhD, of Mount Sinai School of Medicine in New York City and her colleagues, yet the results convey an important message to health care providers, notably that people with a history of substance use shouldn’t be excluded from research exploring HIV and related factors as causes of neurocognitive decline.

HIV infection, alcohol abuse and the use of illicit substances have all been independently linked to neurological problems in people living with HIV. Illicit substances have been shown to potentially suppress immune system function and increase viral replication in the central nervous system. What’s more, some research teams have confirmed that using illicit substances, on top having HIV, can exacerbate neurologic problems.

Because of the documented connection between substance use and neurocognitive problems, people with a history of using, or who are actively using, alcohol and illicit drugs may be left out of scientific research—including treatment protocols—looking specifically at the role of HIV and related factors in the development of HAND. However, not all studies have demonstrated clear links between substance use and neurocognitive decline, hence there is a need for additional research to explore any potential connections. 

To address these disparities—and curtail any bias regarding substance use and neurocognitive problems in people living with HIV—Byrd and her colleagues selected cases from the federally funded CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study that differed in substance use status but were relatively free of other health complications, such as stroke or head injuries. The aim of the study, her group writes, was to determine whether people living with HIV with histories of illicit substance use needed to be viewed differently when conducting research into HAND and other neurocognitive problems.

Roughly 400 HIV-positive individuals were included in the analysis and divided into three groups: 134 had no history of illicit substance use; 134 were “syndromic substance users,” meaning a diagnosable alcohol or illicit drug abuse disorder; and 131 were non-syndromic substance users, who had self-reporting using illicit substances at least five times but could not be categorized as pathological substance abusers.

Based on the results of various neurocognitive tests conducted as part of CHARTER, Byrd’s group failed to reveal any significant differences between the three groups. While there was some evidence of associations between lifetime heroin dosage and poor recall and working memory—as well as between cannabis and cocaine use and verbal fluency—the authors pointed out these connections were weak.

“On the basis of comprehensive neurocognitive testing, HIV-positive participants with either [diagnosable substance use] disorders or self-reported histories of non-syndromic, illicit substance use performed no differently, on average, than a carefully matched group of HIV-positive participants without any indication of significant lifetime substance use,” Byrd and her colleagues conclude. “Similarly, participants with SU histories demonstrated neither a higher rate of HAND diagnoses nor more functional difficulties in everyday life.”

The researchers add: “While this finding does not suggest neurocognitive safety of past substance use, it does indicate that substance use history, even when complex, does not necessarily merit exclusion of patients in short-term analyses of cognition in [HIV-related neurolocognitive] research.”

Search: drugs, alcohol, abuse, use, illicit, recreational, cognitive, neurocognitive, HAND, CHARTER


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (3 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adorableone
    New York
    New York


    Sin_Grinder
    Reno
    Nevada


    sefarady
    New York
    California


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?

Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.